Novo Nordisk A/S Profile Avatar - Palmy Investing

Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…
Biotechnology
DK, Bagsvaerd [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million DKK. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
15,378.00 19,679.00 21,374.00 22,214.00 25,942.00 31,692.00 38,287.00 48,314.00 41,168.00 44,616.00 46,782.00 51,951.00 55,000.00 78,887.00 108,908.00
Operating Cash (Net)
15,378.00 19,679.00 21,374.00 22,214.00 25,942.00 31,692.00 38,287.00 48,314.00 41,168.00 44,616.00 46,782.00 51,951.00 55,000.00 78,887.00 108,908.00
Accounts Receivable
-740.00 -1,878.00 -849.00 -290.00 -1,268.00 -2,134.00 -2,444.00 -4,749.00 69.00 -2,621.00 -2,126.00 -2,822.00 -12,909.00 -9,917.00 -14,210.00
Accounts Payable
921.00 1,805.00 385.00 568.00 233.00 858.00 -23.00 1,084.00 -401.00 1,146.00 -398.00 -641.00 3,153.00 6,717.00 10,019.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-3,046.00 -5,579.00 -3,459.00 -4,070.00 -2,773.00 -2,064.00 -6,098.00 -6,790.00 -6,571.00 -12,080.00 -11,509.00 -22,436.00 -31,605.00 -24,918.00 -43,892.00
Capital Expenditure
-3,065.00 -3,897.00 -3,332.00 -3,622.00 -3,644.00 -4,335.00 -6,406.00 -8,267.00 -8,648.00 -12,410.00 -11,231.00 -22,081.00 -7,385.00 -14,753.00 -38,896.00
Purchases of Investments
- - -2,913.00 - - -501.00 - - - - -3,542.00 -643.00 -40.00 -248.00 -350.00 16,256.00 -7,113.00 -9,735.00 -13,289.00
Sale/Maturity of Investment
- - -453.00 - - - - 840.00 2,232.00 1,532.00 2,087.00 2,082.00 178.00 148.00 12.00 1,172.00 6,645.00 8,293.00
Property, Plant, Equipment (P&PE)
-3,065.00 -3,897.00 -3,332.00 -3,622.00 -3,644.00 -4,335.00 -6,406.00 -8,267.00 -8,648.00 -12,410.00 -11,231.00 -22,081.00 -7,385.00 -14,753.00 -38,896.00
Acquisitions (Net)
- - 1,155.00 - - - - - - - - 2,303.00 1,199.00 1,022.00 368.00 -100.00 -392.00 -18,283.00 -7,075.00 13,090.00
Other Investing Activities
19.00 529.00 -127.00 53.00 31.00 39.00 15.00 -1,166.00 -987.00 32.00 24.00 -16,231.00 4.00 -5,697.00 -13,090.00
Financing Activities
Used Cash (Net)
-10,045.00 -13,220.00 -16,802.00 -20,140.00 -23,639.00 -26,533.00 -30,101.00 -38,887.00 -35,689.00 -34,521.00 -35,484.00 -32,244.00 -25,493.00 -51,797.00 -63,158.00
Debt Repayment
- - - - -507.00 -502.00 - - - - - - - - - - -94.00 -741.00 -950.00 -6,689.00 -13,623.00 -1,467.00
Dividends Paid
- - -4,400.00 -5,700.00 -7,742.00 -9,715.00 -11,866.00 -12,905.00 -23,830.00 -18,844.00 -19,048.00 -19,409.00 -20,121.00 -21,517.00 -25,303.00 -31,767.00
Common Stock
6,512 10,176 10,595 11,896 13,924 14,667 17,196 15,057 16,845 15,567 31,409 16,855 19,447 24,086 29,924
Other Financing Activities
-3,533.00 - - - - -12,398.00 - - - - - - - - - - 94.00 -16,075.00 5,682.00 22,160.00 11,215.00 - -
Cash Balances
Begin of Period
8,726.00 11,034.00 11,960.00 13,057.00 11,053.00 10,513.00 13,676.00 15,850.00 18,461.00 17,158.00 15,629.00 15,411.00 12,226.00 10,719.00 12,653.00
End of Period
11,034.00 11,960.00 13,057.00 11,053.00 10,513.00 13,676.00 15,850.00 18,461.00 17,158.00 15,629.00 15,411.00 12,226.00 10,719.00 12,653.00 14,392.00
Change
2,308.00 926.00 1,097.00 -2,004.00 -540.00 3,163.00 2,174.00 2,611.00 -1,303.00 -1,529.00 -218.00 -3,185.00 -1,507.00 1,934.00 1,739.00
Non-Cash Balances
Depreciation and Amortization
2,551.00 2,467.00 - - 2,693.00 2,799.00 3,435.00 2,959.00 3,193.00 3,182.00 3,925.00 5,661.00 5,753.00 6,025.00 7,362.00 9,413.00
Stock Based Compensation
- - - - - - 308.00 409.00 371.00 442.00 368.00 292.00 414.00 363.00 823.00 1,040.00 1,539.00 2,149.00
Other
2,283.00 2,555.00 3,843.00 -8,872.00 -9,540.00 -4,062.00 -6,440.00 663.00 -7,352.00 -3,968.00 -4,407.00 -3,402.00 -2,489.00 6,260.00 4,917.00
Highlighted metrics
Free Cash Flow (FCF)
12,313.00 15,782.00 18,042.00 18,592.00 22,298.00 27,357.00 31,881.00 40,047.00 32,520.00 32,206.00 35,551.00 29,870.00 47,615.00 64,134.00 70,012.00
Cash Conversion Cycle (CCC)
328.00 266.00 247.00 217.00 207.00 238.00 249.00 255.00 279.00 286.00 292.00 316.00 287.00 231.00 181.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of NVO's Analysis
CIK: 353278 CUSIP: 670100205 ISIN: US6701002056 LEI: - UEI: -
Secondary Listings